pillbase.ru

Xolremdi

Active substance: mavorixafor

mavorixafor

Centralised EU authorisationActive

Marketing holder: Norgine B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • XOLREMDI
    CAPSULE, GELATIN COATED · MAVORIXAFOR 100 mg/1
    83296-100
    X4 Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-2884-7e4d-9a91-e4337f144c78;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006496
Registration status
Active
ATC code
L03AX24
Sources
  • product · EMA · EMEA/H/C/006496 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006496 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006496 · Verified 2026-10-09